Ihab Abd‐Elrahman

525 total citations
11 papers, 443 citations indexed

About

Ihab Abd‐Elrahman is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Ihab Abd‐Elrahman has authored 11 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Ihab Abd‐Elrahman's work include Protease and Inhibitor Mechanisms (3 papers), Cell death mechanisms and regulation (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Ihab Abd‐Elrahman is often cited by papers focused on Protease and Inhibitor Mechanisms (3 papers), Cell death mechanisms and regulation (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Ihab Abd‐Elrahman collaborates with scholars based in Israel, United States and Croatia. Ihab Abd‐Elrahman's co-authors include Galia Blum, Radka Holbová, Smadar Cohen, Tamar Harel-Adar, F. H. Epstein, Jonathan Leor, Natalie Landa‐Rouben, Micha S. Feinberg, Tamar Ben-Mordechai and Yael Ben‐Nun and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Journal of the American College of Cardiology.

In The Last Decade

Ihab Abd‐Elrahman

10 papers receiving 442 citations

Peers

Countries citing papers authored by Ihab Abd‐Elrahman

Since Specialization

Citations

This map shows the geographic impact of Ihab Abd‐Elrahman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ihab Abd‐Elrahman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ihab Abd‐Elrahman more than expected).

Fields of papers citing papers by Ihab Abd‐Elrahman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ihab Abd‐Elrahman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ihab Abd‐Elrahman. The network helps show where Ihab Abd‐Elrahman may publish in the future.

Co-authorship network of co-authors of Ihab Abd‐Elrahman

This figure shows the co-authorship network connecting the top 25 collaborators of Ihab Abd‐Elrahman. A scholar is included among the top collaborators of Ihab Abd‐Elrahman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ihab Abd‐Elrahman. Ihab Abd‐Elrahman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma 2020 ·Oncogene ·Ihab Abd‐Elrahman, Taher Nassar, (unknown), Riki Perlman, Simon Benita, Dina Ben Yehuda	4
2	A Theranostic Cathepsin Activity-Based Probe for Noninvasive Intervention in Cardiovascular Diseases 2019 ·Theranostics ·Tommy Weiss‐Sadan, Yael Ben‐Nun, (unknown), Emmanuelle Merquiol, Ihab Abd‐Elrahman, Israel Gotsman, Galia Blum	24
3	Cathepsin Activity-Based Probes and Inhibitor for Preclinical Atherosclerosis Imaging and Macrophage Depletion 2016 ·PLoS ONE ·Ihab Abd‐Elrahman, Hisanori Kosuge, (unknown), Yael Ben‐Nun, Karen Meir, Chen Rubinstein, Matthew Bogyo, Michael V. McConnell, Galia Blum	33
4	Characterizing Cathepsin Activity and Macrophage Subtypes in Excised Human Carotid Plaques 2016 ·Stroke ·Ihab Abd‐Elrahman, Karen Meir, Hisanori Kosuge, Yael Ben‐Nun, (unknown), Chen Rubinstein, Yaacov Samet, Michael V. McConnell, Galia Blum	52
5	α-Defensins Induce a Post-translational Modification of Low Density Lipoprotein (LDL) That Promotes Atherosclerosis at Normal Levels of Plasma Cholesterol 2015 ·Journal of Biological Chemistry ·(unknown), (unknown), Ihab Abd‐Elrahman, (unknown), Galia Blum, (unknown), (unknown), Douglas B. Cines, Abd Al‐Roof Higazi	16
6	Foam cell‐derived 4‐hydroxynonenal induces endothelial cell senescence in a TXNIP‐dependent manner 2015 ·Journal of Cellular and Molecular Medicine ·Yael Riahi, Nurit Kaiser, Guy Cohen, Ihab Abd‐Elrahman, Galia Blum, Oz M. Shapira, (unknown), Maya Simionescu, Anca V. Sima, Neven Žarković, Kamelija Žarković, Marica Orioli, Giancarlo Aldini, Erol Cerasi, Gil Leibowitz, Shlomo Sasson	48
7	Macrophage Subpopulations Are Essential for Infarct Repair With and Without Stem Cell Therapy 2013 ·Journal of the American College of Cardiology ·Tamar Ben-Mordechai, Radka Holbová, Natalie Landa‐Rouben, Tamar Harel-Adar, Micha S. Feinberg, Ihab Abd‐Elrahman, Galia Blum, F. H. Epstein, (unknown), Smadar Cohen, Jonathan Leor	219
8	Differential regulation of the apoptotic machinery during megakaryocyte differentiation and platelet production by inhibitor of apoptosis protein Livin 2013 ·Cell Death and Disease ·Ihab Abd‐Elrahman, V Deutsch, Marjorie Pick, Sigi Kay, Tzahi Neuman, Riki Perlman, Dina Ben‐Yehuda	12
9	Clinical and Molecular Significance of Tumor Necrosis In Newly Diagnosed Patients with Hodgkin's Lymphoma and Diffuse Large B Cell Lymphoma 2010 ·Blood ·Ihab Abd‐Elrahman, (unknown), Tzahi Neuman, Liat Appelbaum, (unknown), Riki Perlman, Dina Ben‐Yehuda	0
10	The Inhibitor of Apoptosis Protein Livin (ML-IAP) Plays a Dual Role in Tumorigenicity 2009 ·Cancer Research ·Ihab Abd‐Elrahman, (unknown), Tzahi Neuman, Boaz Nachmias, Riki Perlman, Dina Ben‐Yehuda	34
11	The Role of Livin, An Inhibitor of Apoptosis Protein, in Thrombopoiesis. 2008 ·Blood ·Ihab Abd‐Elrahman, Varda Deutsch, (unknown), (unknown), (unknown), Boaz Nachmias, Riki Perlman, Dina Ben‐Yehuda	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact